These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 11332630

  • 1. Posttranscriptional mechanisms of glucocorticoid antiproliferative effects: glucocorticoids inhibit IL-6-induced proliferation of B9 hybridoma cells.
    Almawi WY, Tamim H.
    Cell Transplant; 2001; 10(2):161-4. PubMed ID: 11332630
    [Abstract] [Full Text] [Related]

  • 2. Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation.
    Schwabe M, Cox GW, Bosco MC, Prohaska R, Kung HF.
    Cell Immunol; 1996 Feb 25; 168(1):117-21. PubMed ID: 8599834
    [Abstract] [Full Text] [Related]

  • 3. Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma.
    Almawi WY, Lipman ML, Stevens AC, Zanker B, Hadro ET, Strom TB.
    J Immunol; 1991 May 15; 146(10):3523-7. PubMed ID: 1902856
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Partial mediation of glucocorticoid antiproliferative effects by lipocortins.
    Almawi WY, Saouda MS, Stevens AC, Lipman ML, Barth CM, Strom TB.
    J Immunol; 1996 Dec 15; 157(12):5231-9. PubMed ID: 8955167
    [Abstract] [Full Text] [Related]

  • 7. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells.
    Yano A, Fujii Y, Iwai A, Kageyama Y, Kihara K.
    Clin Cancer Res; 2006 May 15; 12(10):3003-9. PubMed ID: 16707595
    [Abstract] [Full Text] [Related]

  • 8. Glucocorticoid inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts: evidence for transcriptional and post-transcriptional regulatory mechanisms.
    Zitnik RJ, Whiting NL, Elias JA.
    Am J Respir Cell Mol Biol; 1994 Jun 15; 10(6):643-50. PubMed ID: 7516173
    [Abstract] [Full Text] [Related]

  • 9. Biological activity of recombinant chicken interleukin-6 in chicken hybridoma cells.
    Nishimichi N, Aosasa M, Kawashima T, Horiuchi H, Furusawa S, Matsuda H.
    Vet Immunol Immunopathol; 2005 Jun 15; 106(1-2):97-105. PubMed ID: 15910996
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of glucocorticoids on urocortin-mediated increases in interleukin-6 gene expression in rat aortic smooth muscle cells.
    Kageyama K, Hanada K, Nigawara T, Furukawa K, Terui K, Ogura E, Motomura S, Suda T.
    Peptides; 2007 May 15; 28(5):1059-67. PubMed ID: 17346851
    [Abstract] [Full Text] [Related]

  • 11. Glucocorticoid-induced keratinocyte-derived interleukin-1 receptor antagonist(s).
    Stosić-Grujicić S, Lukić ML.
    Immunology; 1992 Feb 15; 75(2):293-8. PubMed ID: 1532379
    [Abstract] [Full Text] [Related]

  • 12. Vitamin B6 modulates glucocorticoid-dependent gene transcription in a promoter- and cell type-specific manner.
    Bamberger CM, Else T, Ellebrecht I, Milde-Langosch K, Pankoke D, Beil FU, Bamberger AM.
    Exp Clin Endocrinol Diabetes; 2004 Nov 15; 112(10):595-600. PubMed ID: 15578335
    [Abstract] [Full Text] [Related]

  • 13. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel "slow death" phenotype.
    Thompson EA.
    Cancer Res; 1991 Oct 15; 51(20):5544-50. PubMed ID: 1913673
    [Abstract] [Full Text] [Related]

  • 14. Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis.
    Li QF, Wu CT, Duan HF, Sun HY, Wang H, Lu ZZ, Zhang QW, Liu HJ, Wang LS.
    Br J Haematol; 2007 Sep 15; 138(5):632-9. PubMed ID: 17686057
    [Abstract] [Full Text] [Related]

  • 15. The suppression of cellular proliferation in SV40-transformed 3T3 cells by glucocorticoids.
    Young DV, Dean MC.
    J Cell Physiol; 1980 Feb 15; 102(2):223-31. PubMed ID: 6246128
    [Abstract] [Full Text] [Related]

  • 16. Effects of glucocorticoid on proliferation, differentiation, and glucocorticoid receptor expression in human ovarian carcinoma cell line 3AO.
    Xu MJ, Fang GE, Liu YJ, Song LN.
    Acta Pharmacol Sin; 2002 Sep 15; 23(9):819-23. PubMed ID: 12230951
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effect of physiological concentrations of cortisol but not estradiol on interleukin (IL)-6 production by human osteoblast-like cell lines with different constitutive IL-6 expression.
    Dovio A, Sartori ML, Masera RG, Racca S, Angeli A.
    Cytokine; 2001 Jul 07; 15(1):47-52. PubMed ID: 11509008
    [Abstract] [Full Text] [Related]

  • 18. Antagonistic and synergistic effects of glucocorticoids and IL-7 on CD4+ T cell activation.
    Cima I, Fuhrer A, Brunner T.
    Immunol Lett; 2006 Jul 15; 106(1):99-102. PubMed ID: 16723155
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells.
    Yano A, Fujii Y, Iwai A, Kawakami S, Kageyama Y, Kihara K.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6012-7. PubMed ID: 17062674
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human interleukin-1 inhibits the induction by dexamethasone of alkaline phosphatase activity in murine capillary endothelial cells.
    Mulkins MA, Allison AC.
    J Cell Physiol; 1987 Dec 15; 133(3):539-45. PubMed ID: 3500955
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.